The Relationship Between Fibromyalgia Syndrome Parameters With Disease-Pain Severity and the Quality Of Life

Study Overview
=================
Brief Summary
-----------------
In this study, the investigators aim to evaluate the relationship between disease severity, quality of life, anxiety and pain level in patients diagnosed with Fibromyalgia Syndrome (FMS) with the parameters according to the American College of Rheumatology (ACR) 2016 diagnostic criteria. According to the 2016 ACR diagnostic criteria, there are 2 separate scales: Widespread Pain Index (WPI) and Symptom Severity (SS) . The relationship between these 2 parameters and the Fibromyalgia Impact Questionnaire, the World Health Organization Short Quality of Life Questionnaire, and the McGill Melzack Pain Questionnaire and Beck Anxiety Questionnaire will be examined.

Detailed Description
-----------------
The aim of this study is to observe the relationship between the WPI and SS parameters in the ACR 2016 criteria for fibromyalgia, separately, with the severity of the disease, pain level, quality of life and anxiety level. Accordingly, the investigators aim to evaluate whether WPI or SS has priority in assessing the severity of the disease. There is no study in the literature comparing the importance of the 2016 ACR diagnostic parameters on the disease effect. In this context, this study will be the first study in the literature and will be very valuable. Patients visiting the outpatient clinic with FMS diagnosis will be evaluated. Patients will be asked to fill the World Health Organization Short Quality of Life Questionnaire, and the McGill Melzack Pain Questionnaire and Beck Anxiety Questionnaire . The patients will be assed by an experienced Physical Medicine and Rehabilitation specialist for SS and WPI scores.

Official Title
-----------------
The Relationship Between Fibromyalgia Syndrome Parameters With Disease Severity, Pain and the Quality Of Life

Conditions
-----------------
Fibromyalgia Syndrome, Anxiety Disorders, Depressive Disorder

Intervention / Treatment
-----------------
* Diagnostic Test: Questionary


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Diagnosed as FMS according to ACR 2016 criterias Exclusion Criteria: History of Malignity History of Rheumatological Disease

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 65 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| FIBROMIYALGIA GROUP<br>Patients aged between 18-65 who are diagnosed as FMS according to AACR 2016 criterias willing to take part in the study. | Diagnostic Test: Questionary<br>* Patients will be asked to fill Fibromyalgia Impact Questionary, WHO Short Quality of Life Questionary, McGill Pain Questionary and Beck Anxiety Questionary<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Widespread Pain Index Score | Widespread Pain Index Score, Ranging from 0-19. Higher scores mean higher pain scores. | at the start of the study | 
| Symptom Severity Score | Symptom Severity Score. Ranging from 0-12. Higher scores mean higher symptom scores. | at the start of the study | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Beck Anxiety Score | Beck Anxiety Score, Ranging from 0-63. Higher scores mean anxiety getting worse. | at the start of the study | 
| WHO Short Quality of Life Score | WHO Short Quality of Life Score, Ranging from 0-100. Higher scores mean better quality of life. | at the start of the study |